Chen Y, Shao W, Wang X, Geng K, Wang W, Li Y
Pharm Res. 2024; 41(11):2199-2212.
PMID: 39557814
DOI: 10.1007/s11095-024-03789-w.
Tsirizani L, Mohsenian Naghani S, Waalewijn H, Szubert A, Mulenga V, Chabala C
J Antimicrob Chemother. 2024; 79(11):2990-2998.
PMID: 39302766
PMC: 11531812.
DOI: 10.1093/jac/dkae319.
Gupta S, Singh P, Ali V, Verma M
Oncol Rev. 2020; 14(2):448.
PMID: 32676170
PMC: 7358983.
DOI: 10.4081/oncol.2020.448.
Perez-Guerrero E, Gamez-Nava J, Munoz-Valle J, Cardona-Munoz E, Bonilla-Lara D, Fajardo-Robledo N
Clin Exp Med. 2017; 18(1):109-117.
PMID: 28243944
DOI: 10.1007/s10238-017-0459-0.
Katayama K, Fujiwara C, Noguchi K, Sugimoto Y
Sci Rep. 2016; 6:36134.
PMID: 27786305
PMC: 5081560.
DOI: 10.1038/srep36134.
Population pharmacokinetic modelling of the changes in atazanavir plasma clearance caused by ritonavir plasma concentrations in HIV-1 infected patients.
Molto J, Estevez J, Miranda C, Cedeno S, Clotet B, Valle M
Br J Clin Pharmacol. 2016; 82(6):1528-1538.
PMID: 27447851
PMC: 5099552.
DOI: 10.1111/bcp.13072.
How the Probability and Potential Clinical Significance of Pharmacokinetically Mediated Drug-Drug Interactions Are Assessed in Drug Development: Desvenlafaxine as an Example.
Macaluso M, Nichols A, Preskorn S
Prim Care Companion CNS Disord. 2015; 17(2).
PMID: 26445693
PMC: 4560193.
DOI: 10.4088/PCC.14r01710.
Binary and ternary combinations of anti-HIV protease inhibitors: effect on gene expression and functional activity of CYP3A4 and efflux transporters.
Kwatra D, Vadlapudi A, Vadlapatla R, Khurana V, Pal D, Mitra A
Drug Metabol Drug Interact. 2014; 29(2):101-10.
PMID: 24399676
PMC: 4407648.
DOI: 10.1515/dmdi-2013-0056.
Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells.
Dupuis M, Ascione A, Palmisano L, Vella S, Cianfriglia M
BMC Pharmacol Toxicol. 2013; 14:47.
PMID: 24053678
PMC: 3852167.
DOI: 10.1186/2050-6511-14-47.
PharmGKB summary: cyclosporine and tacrolimus pathways.
Barbarino J, Staatz C, Venkataramanan R, Klein T, Altman R
Pharmacogenet Genomics. 2013; 23(10):563-85.
PMID: 23922006
PMC: 4119065.
DOI: 10.1097/FPC.0b013e328364db84.
Renal transplantation in HIV patients: A series of four cases.
Agarwal D, Hota J, Nag N, Mehta S
Indian J Nephrol. 2012; 22(2):139-42.
PMID: 22787319
PMC: 3391814.
DOI: 10.4103/0971-4065.97139.
Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy.
Zorrilla C, Tamayo-Agrait V
HIV AIDS (Auckl). 2011; 1:41-53.
PMID: 22096378
PMC: 3218681.
DOI: 10.2147/hiv.s6326.
Developmental regulation of P-glycoprotein activity within thymocytes results in increased anti-HIV protease inhibitor activity.
Haraguchi S, Ho S, Morrow M, Goodenow M, Sleasman J
J Leukoc Biol. 2011; 90(4):653-60.
PMID: 21504949
PMC: 3409632.
DOI: 10.1189/jlb.0111-009.
Interaction potential of etravirine with drug transporters assessed in vitro.
Zembruski N, Haefeli W, Weiss J
Antimicrob Agents Chemother. 2010; 55(3):1282-4.
PMID: 21189339
PMC: 3067076.
DOI: 10.1128/AAC.01527-10.
Renal transplantation in a HIV positive patient.
Mann A, Soundararajan P, Shroff S
Indian J Nephrol. 2010; 19(3):119-21.
PMID: 20436733
PMC: 2859478.
DOI: 10.4103/0971-4065.57110.
Role of multidrug transporters in neurotherapeutics.
Jose M, Thomas S
Ann Indian Acad Neurol. 2010; 12(2):89-98.
PMID: 20142853
PMC: 2812747.
DOI: 10.4103/0972-2327.53076.
Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals.
Yilmaz A, Izadkhashti A, Price R, Mallon P, De Meulder M, Timmerman P
AIDS Res Hum Retroviruses. 2009; 25(4):457-61.
PMID: 19320601
PMC: 2853865.
DOI: 10.1089/aid.2008.0216.
Inhibition of placental P-glycoprotein: impact on indinavir transfer to the foetus.
Sudhakaran S, Rayner C, Li J, Kong D, Gude N, Nation R
Br J Clin Pharmacol. 2007; 65(5):667-73.
PMID: 18093255
PMC: 2432476.
DOI: 10.1111/j.1365-2125.2007.03067.x.
HIV-1 integrase inhibitors are substrates for the multidrug transporter MDR1-P-glycoprotein.
Cianfriglia M, Dupuis M, Molinari A, Verdoliva A, Costi R, Galluzzo C
Retrovirology. 2007; 4:17.
PMID: 17343726
PMC: 1828167.
DOI: 10.1186/1742-4690-4-17.
Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasma.
Sudhakaran S, Rayner C, Li J, Kong D, Gude N, Nation R
Br J Clin Pharmacol. 2006; 63(3):315-21.
PMID: 16981898
PMC: 2000742.
DOI: 10.1111/j.1365-2125.2006.02766.x.
